Chronobiologic considerations in human growth hormone therapy

M. Cassandra Matustik, Richard W. Furlanetto, Walter Meyer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Because there is a striking diurnal variation in serum growth hormone concentration, the effect of the time of administration of growth hormone replacement therapy was examined in nine children with growth hormone deficiency. No differences in growth rate or somatomedin concentration were noted between morning and evening treatment schedules. Somatomedin concentrations were not constant over the 48 hours between growth hormone injections, and the peak value occurred approximately 24 hours after the growth hormone injection. Thus the timing of growth hormone administration is not an important aspect of growth hormone therapy.

Original languageEnglish (US)
Pages (from-to)543-546
Number of pages4
JournalThe Journal of pediatrics
Volume103
Issue number4
DOIs
StatePublished - 1983

Fingerprint

Human Growth Hormone
Growth Hormone
Somatomedins
Therapeutics
Injections
Hormone Replacement Therapy
Appointments and Schedules
Growth
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Chronobiologic considerations in human growth hormone therapy. / Matustik, M. Cassandra; Furlanetto, Richard W.; Meyer, Walter.

In: The Journal of pediatrics, Vol. 103, No. 4, 1983, p. 543-546.

Research output: Contribution to journalArticle

Matustik, M. Cassandra ; Furlanetto, Richard W. ; Meyer, Walter. / Chronobiologic considerations in human growth hormone therapy. In: The Journal of pediatrics. 1983 ; Vol. 103, No. 4. pp. 543-546.
@article{6dd8232fb1e54505b9392a6c91a67cc2,
title = "Chronobiologic considerations in human growth hormone therapy",
abstract = "Because there is a striking diurnal variation in serum growth hormone concentration, the effect of the time of administration of growth hormone replacement therapy was examined in nine children with growth hormone deficiency. No differences in growth rate or somatomedin concentration were noted between morning and evening treatment schedules. Somatomedin concentrations were not constant over the 48 hours between growth hormone injections, and the peak value occurred approximately 24 hours after the growth hormone injection. Thus the timing of growth hormone administration is not an important aspect of growth hormone therapy.",
author = "Matustik, {M. Cassandra} and Furlanetto, {Richard W.} and Walter Meyer",
year = "1983",
doi = "10.1016/S0022-3476(83)80580-0",
language = "English (US)",
volume = "103",
pages = "543--546",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Chronobiologic considerations in human growth hormone therapy

AU - Matustik, M. Cassandra

AU - Furlanetto, Richard W.

AU - Meyer, Walter

PY - 1983

Y1 - 1983

N2 - Because there is a striking diurnal variation in serum growth hormone concentration, the effect of the time of administration of growth hormone replacement therapy was examined in nine children with growth hormone deficiency. No differences in growth rate or somatomedin concentration were noted between morning and evening treatment schedules. Somatomedin concentrations were not constant over the 48 hours between growth hormone injections, and the peak value occurred approximately 24 hours after the growth hormone injection. Thus the timing of growth hormone administration is not an important aspect of growth hormone therapy.

AB - Because there is a striking diurnal variation in serum growth hormone concentration, the effect of the time of administration of growth hormone replacement therapy was examined in nine children with growth hormone deficiency. No differences in growth rate or somatomedin concentration were noted between morning and evening treatment schedules. Somatomedin concentrations were not constant over the 48 hours between growth hormone injections, and the peak value occurred approximately 24 hours after the growth hormone injection. Thus the timing of growth hormone administration is not an important aspect of growth hormone therapy.

UR - http://www.scopus.com/inward/record.url?scp=0020553215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020553215&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(83)80580-0

DO - 10.1016/S0022-3476(83)80580-0

M3 - Article

C2 - 6684678

AN - SCOPUS:0020553215

VL - 103

SP - 543

EP - 546

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 4

ER -